Atypical fibroxanthoma of the skin

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Atypical fibroxanthomas are rare cutaneous neoplasms classified among fibrohistiocytic tumors. They most commonly develop in elderly individuals with a history of chronic sun damage and are typically located on the head, shoulders, and upper back. Atypical fibroxanthoma is frequently associated with other skin tumors and is characterized by locally destructive growth with extremely rare metastases (1%–2% of cases). However, in immunosuppressed patients, the tumor may demonstrate more aggressive behavior. The clinical presentation of atypical fibroxanthoma is nonspecific. It appears as a pink or reddish-pink nodule or papule. Atypical fibroxanthoma lacks specific dermatoscopic features; common findings include polymorphous vessels (linear, dotted, glomerular, arborizing) and chrysalis structures, which are not sufficient to reliably differentiate it from clinically similar lesions. Its resemblance to aggressive neoplasms such as amelanotic melanoma and Merkel cell carcinoma presents a diagnostic challenge. A definitive diagnosis relies on characteristic histopathologic and immunohistochemical findings. The gold standard of treatment is wide local excision. Mohs micrographic surgery may be considered. Other treatment modalities are not recommended because of the high recurrence rate.

We report a case of atypical fibroxanthoma in a 72-year-old male with photodamaged skin and a history of other skin tumors (basal cell carcinomas self-treated with liquid nitrogen cryotherapy). Histopathologic examination revealed an ulcerated, polymorphic, poorly differentiated tumor with marked anaplasia and areas of epithelioid and spindle-cell morphology. The differential diagnosis included melanoma, fibrosarcoma, and atypical fibroxanthoma. The patient underwent wide excision of the tumor, with the specimen submitted for histologic and immunohistochemical analysis. The postoperative period was uneventful with scar formation, and no recurrence was observed during follow-up.

About the authors

Ekaterina Yu. Vertieva

The First Sechenov Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: ivertieva@gmail.com
ORCID iD: 0000-0002-1088-2911
SPIN-code: 3712-8453

MD, Cand. Sci. (Medicine)

Russian Federation, Moscow

Alexander S. Tertychnyy

The First Sechenov Moscow State Medical University (Sechenov University)

Email: atertychyy@gmail.com
ORCID iD: 0000-0001-5635-6100
SPIN-code: 5150-0535

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow

Larisa V. Tsoy

The First Sechenov Moscow State Medical University (Sechenov University)

Email: dr.lvtsoy@gmail.com
ORCID iD: 0000-0001-9072-2311
SPIN-code: 9581-6228

MD, Cand. Sci. (Medicine), Associate Professor

Russian Federation, Moscow

Diana A. Khorosheva

The First Sechenov Moscow State Medical University (Sechenov University)

Email: 5_97@inbox.ru
ORCID iD: 0009-0006-1296-5848
Russian Federation, Moscow

Tatiana M. Bocharova

Saratov State Medical University named after V.I. Razumovsky

Email: tatuana.bocharova@yandex.ru
ORCID iD: 0009-0002-4361-1357
Russian Federation, Saratov

References

  1. Rosenfeld D, Alam M, van Tine B, Council ML. Atypical fibroxanthoma: A malignant tumor of the skin and soft tissue. J Am Acad Dermatol. 2020;83(6):e429–e430 doi: 10.1016/j.jaad.2020.07.022
  2. Agaimy A. The many faces of atypical fibroxanthoma. Semin Diagn Pathol. 2023;40(4):306–312. doi: 10.1053/j.semdp.2023.06.001
  3. Ríos-Viñuela E, Pons Benavent M, Monteagudo C, et al. Atypical fibroxanthoma and pleomorphic dermal sarcoma: A two-center retrospective study of 74 cases. Actas Dermosifiliogr. 2022;113(6):654–656. doi: 10.1016/j.ad.2021.09.008
  4. Helwig EB, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer. 1986;57(2):368–376. doi: 10.1002/1097-0142(19860115)57:2<368::aid-cncr2820570230>3.0.co;2-n
  5. Bitel A, Schönlebe J, Krönert C, Wollina U. Atypical fibroxanthoma: An analysis of 105 tumors. Dermatol Ther. 2020;33(6):e13962. doi: 10.1111/dth.13962
  6. Pitarch G. Dermoscopic rainbow pattern in atypical fibroxanthoma. Actas Dermosifiliogr. 2014;105(1):97–99. doi: 10.1016/j.ad.2012.11.010
  7. Alves R, Ocaña J, Vale E, et al. Basal cell carcinoma and atypical fibroxanthoma: An unusual collision tumor. J Am Acad Dermatol. 2010;63(3):e74–e76. doi: 10.1016/j.jaad.2009.11.685
  8. Fisher JC, Jones M, Hurd DS. Atypical fibroxanthoma: A case report and literature review. J Am Osteopath Coll Dermatol. 2017;37(2):17–19.
  9. Piras V, Ferreli C, Atzori L, et al. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: A pitfall in dermatopathology. Pathologica. 2020;112(2):105–109. doi: 10.32074/1591-951X-39-19
  10. Nguyen CM, Chong K, Cassarino D. Clear cell atypical fibroxanthoma: A case report and review of the literature. J Cutan Pathol. 2016;43(6):538–542. doi: 10.1111/cup.12696

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Atypical fibroxanthoma: red-pink coloured nodule on the background of photodamaged skin.

Download (479KB)
3. Fig. 2. Dermatoscopic picture of atypical fibroxanthoma: atypical vessels, chrysalides, crusts.

Download (305KB)
4. Fig. 3. Squamous cell carcinoma.

Download (375KB)
5. Fig. 4. Dermatoscopic picture of squamous cell carcinoma: atypical linear and point vessels.

Download (255KB)
6. Fig. 5. Atypical fibroxanthoma (haematoxylin and eosin staining, ×100).

Download (875KB)
7. Fig. 6. Atypical fibroxanthoma (haematoxylin and eosin staining, ×200).

Download (637KB)
8. Fig. 7. Atypical fibroxanthoma, ×100. Immunohistochemistry study with antibodies to CD10: diffuse marked expression.

Download (855KB)
9. Fig. 8. Atypical fibroxanthoma, ×100. Immunohistochemistry study with antibodies to CD68: diffuse marked expression.

Download (765KB)

Copyright (c) 2025 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).